Original articleTargeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles

Add time:08/24/2019    Source:sciencedirect.com

Further studies on 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles as anticancer agents against breast cancer are reported, allowing to demonstrate the potential of these compounds for the therapy of the triple-negative breast cancer, the most challenging tumors in clinical practice. These compounds were assayed for their in vitro cytotoxicity on several human breast cancer cell lines (MCF7, HCC1954 and HCC1806 cell lines). Particularly interesting were the results obtained for 4-hydroxyphenyl substituted derivative, which proved to be the most promising compound regarding HCC1806 cell line, a triple-negative breast cancer. The effects of the two most active compounds on cell survival, viability, cell cycle, DNA damage and expression of proteins related to cell death pathways were studied. The reported results consolidate the potential of 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles for the therapy of breast cancer, particularly the triple-negative.

We also recommend Trading Suppliers and Manufacturers of 1,2-bis-(Hydroxymethyl)-o-carborane (cas 19610-37-8). Pls Click Website Link as below: cas 19610-37-8 suppliers

Prev:Tetrahedron: Asymmetry Report Number 148Asymmetric and enantiospecific syntheses of 1-hydroxymethyl pyrrolizidine alkaloids
Next:Practical way for the synthesis of 3,3′-bis-substituted benzo[d][1,2]oxaphosphole 2-oxides by phosphonylation of in situ generated o-quinone methides)